MX9203760A - Metodo para tratar y prevenir la perdida de masa osea. - Google Patents

Metodo para tratar y prevenir la perdida de masa osea.

Info

Publication number
MX9203760A
MX9203760A MX9203760A MX9203760A MX9203760A MX 9203760 A MX9203760 A MX 9203760A MX 9203760 A MX9203760 A MX 9203760A MX 9203760 A MX9203760 A MX 9203760A MX 9203760 A MX9203760 A MX 9203760A
Authority
MX
Mexico
Prior art keywords
vitamin
alpha
bone mass
active
treating
Prior art date
Application number
MX9203760A
Other languages
English (en)
Inventor
Hector F Deluca
Charles W Bishop
Richard B Mazess
John C Gallagher
Original Assignee
Bone Care Internationational I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Internationational I filed Critical Bone Care Internationational I
Publication of MX9203760A publication Critical patent/MX9203760A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Processing Of Solid Wastes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Disintegrating Or Milling (AREA)
  • Fertilizers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9203760A 1988-08-02 1992-06-29 Metodo para tratar y prevenir la perdida de masa osea. MX9203760A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22737188A 1988-08-02 1988-08-02

Publications (1)

Publication Number Publication Date
MX9203760A true MX9203760A (es) 1992-09-01

Family

ID=22852835

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203760A MX9203760A (es) 1988-08-02 1992-06-29 Metodo para tratar y prevenir la perdida de masa osea.

Country Status (11)

Country Link
EP (1) EP0381750B1 (es)
JP (1) JP3030854B2 (es)
AT (1) ATE114471T1 (es)
AU (1) AU634490B2 (es)
CA (1) CA1341408C (es)
DE (1) DE68919673T2 (es)
GB (1) GB2231794B (es)
MX (1) MX9203760A (es)
NL (1) NL8920901A (es)
SE (1) SE9001308D0 (es)
WO (1) WO1990001321A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6096876A (en) * 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
US20060270640A1 (en) * 2004-02-18 2006-11-30 Mercian Corporation Method of preventing, medicating, and/or treating hypocalcemia of domestic mammal
CN101668532B (zh) * 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
DE3490215T (de) * 1983-05-09 1985-05-15 Wisconsin Alumni Research Foundation, Madison, Wis. Verfahren zur Herstellung von 1α,25-dihydroxyliertem Vitamin D↓2↓ und verwandten Verbindungen
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass

Also Published As

Publication number Publication date
JP3030854B2 (ja) 2000-04-10
SE9001308L (sv) 1990-04-10
NL8920901A (nl) 1990-07-02
WO1990001321A3 (en) 1990-05-17
SE9001308D0 (sv) 1990-04-10
JPH03501388A (ja) 1991-03-28
AU634490B2 (en) 1993-02-25
GB2231794B (en) 1992-01-15
DE68919673T2 (de) 1995-06-01
CA1341408C (en) 2002-12-10
AU4220389A (en) 1990-03-05
GB9006990D0 (en) 1990-08-29
ATE114471T1 (de) 1994-12-15
GB2231794A (en) 1990-11-28
EP0381750B1 (en) 1994-11-30
WO1990001321A2 (en) 1990-02-22
DE68919673D1 (de) 1995-01-12
EP0381750A1 (en) 1990-08-16

Similar Documents

Publication Publication Date Title
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
RU92004521A (ru) Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
IL78342A (en) Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
EP1064000A4 (en) VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS
BR9807675A (pt) Processos para fabricação de um complexo argimina-silicato-inositol, para prevenir ou inibir a arterioesclerose em um indivìduo, para suplementação dietética de arginina, para prevenção da desmineralização de ossos ou degradação de cartilagens em um indivìduo com necessidade do mesmo, para tratamento de um mamìfero para aliviar os efeitos patológicos da osteoporose, osteogenesis imperfecta, fraturas ósseas, osteoartrites e outras doenças de ossos e cartilagens, complexo arginina-silicato-inositol, uso do mesmo, e formulação farmacêutica opositora da desmineralização óssea e inibidora da degradação de cartilagem
EP0401903A3 (en) The use of vanilloids for the treatment of respiratory diseases or disorders
SE7612534L (sv) Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
RU93054017A (ru) Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
MX9203760A (es) Metodo para tratar y prevenir la perdida de masa osea.
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
RU2003136733A (ru) Пероральное введение паратиреоидного гормона и кальцитонина
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69424747D1 (de) Pharmazeutische Zusammensetzung zur Vorbeugung oder Behandlung von Knochenbrüchen
GB8921516D0 (en) Medicaments
KR980700083A (ko) 골다공증 치료 주기용 키트(KIT for Osteoporosis Treatment Cycle)
ZA898143B (en) Medicaments
DE69528068D1 (de) Conagenine zur prävention und behandlung von diarrhöe
ES2123666T3 (es) Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
JPS56103114A (en) Drug for osteoporosis comprising 24r- hydroxycholecalciferol
Sina et al. Adrenaline in prevention and treatment of accidents of therapy by arsobal. A study from 776 cases of T. gambiense African human trypanosomiasis treated in Fontem(U. R. of Cameroon).
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
TH6683A (th) องค์ประกอบของการรักษาผิวหนัง